Sign inJoin waitlistJoin the waitlist

David Baidal

Associate Professor of Clinical Medicine · University of Miami/Jackson Health System

Credentials: · · · ·

History

University of Miami/Jackson Health System
Present

Beth Israel Deaconess Medical Center
2003–2005
Internal Medicine
Jackson Memorial Hospital
2000–2003
UNIV CATOLICA DE SANTIAGO, GUAYAQUIL
1996–2000

Research

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
Stem Cells Translational Medicine · 2021 · 317 citations
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience
American Journal of Transplantation · 2005 · 290 citations
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes
Diabetes Care · 2018 · 159 citations

RA
Rodolfo Alejandro
57 papers
Camillo Ricordi
54 papers
TF
Tatiana Froud
28 papers
RF
Raquel Faradji
16 papers
RP
Raffaella Poggioli
14 papers
GP
Gaston Ponte
12 papers · 12 as a resident
GS
Gennaro Selvaggi
10 papers
KM
Kathy Monroy
9 papers · 7 as a resident
JF
Jacqueline Ferreira
6 papers
Francesco Vendrame
5 papers
Antoinette Moran
4 papers
Henry Rodriguez
4 papers

Grants

Clinical Affiliate of the Type 1 Diabetes Trialnet
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $785.7K · University of Miami School of Medicine
2009–2020

Clinical trials

Low-dose IL-2 in Established T1D - The "PROREG" Study
Principal investigator · Withdrawn · Phase 1, Phase 2
Jay S. Skyler
2023–2028
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Site PI · Recruiting · Phase 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2026–2028
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Site PI · Recruiting · Phase 1, Phase 2
City of Hope Medical Center
2026–2031
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Site PI · Recruiting · Phase 1
GentiBio, Inc
2025–2028